Tranilcipromin
 | |
 | |
| Klinički podaci | |
|---|---|
| Prodajno ime | Dl-Tranylcypromine, Parnate, Transamine |
| Drugs.com | Monografija |
| Način primene | Oralno |
| Farmakokinetički podaci | |
| Poluvreme eliminacije | 1,5-3,2 h |
| Identifikatori | |
| CAS broj | 155-09-9  |
| ATC kod | N06AF04 (WHO) |
| PubChem | CID 441233 |
| DrugBank | DB00752 |
| ChemSpider | 390008 |
| KEGG | C07155 |
| ChEMBL | CHEMBL1179 |
| Hemijski podaci | |
| Formula | C9H11N |
| Molarna masa | 133,190 |
| |
| |
| Fizički podaci | |
| Tačka topljenja | 79—80 °C (174—176 °F) |
Tranilcipromin je organsko jedinjenje, koje sadrži 9 atoma ugljenika i ima molekulsku masu od 133,190 Da.[1][2][3][4]
Osobine
[уреди | уреди извор]| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 1 |
| Broj donora vodonika | 1 |
| Broj rotacionih veza | 1 |
| Particioni koeficijent[5] (ALogP) | 1,2 |
| Rastvorljivost[6] (logS, log(mol/L)) | -1,9 |
| Polarna površina[7] (PSA, Å2) | 26,0 |
Reference
[уреди | уреди извор]- ^ Frieling, H.; Bleich, S. (2006 Aug). „Tranylcypromine: new perspectives on an old drug”. Eur Arch Psychiatry Clin Neurosci. 256 (5): 268—73. PMID 16927039. doi:10.1007/s00406-006-0660-8. Проверите вредност парамет(а)ра за датум:
|date=(помоћ) - ^ Nolen WA: [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression] Nolen, W. A. (2003 Oct 4). „Classical monoamine oxidase inhibitor: Not registered for, but still a place in the treatment of depression”. Ned Tijdschr Geneeskd. 147 (40): 1940—3. PMID 14574774. Проверите вредност парамет(а)ра за датум:
|date=(помоћ) - ^ Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'Omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—D1041. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
- ^ Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—D906. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.
- ^ Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o.
- ^ Tetko, Igor V.; Tanchuk, Vsevolod Yu.; Kasheva, Tamara N.; Villa, Alessandro E. P. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- ^ Ertl, Peter; Rohde, Bernhard; Selzer, Paul (2000). „Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
[уреди | уреди извор]- Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
[уреди | уреди извор]
 | Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |
